India Blood-based Biomaker For Sports Medicine Market Size & Outlook
India blood-based biomaker for sports medicine market, 2018-2030 (US$M)
Related Markets
India blood-based biomaker for sports medicine market highlights
- The India blood-based biomaker for sports medicine market generated a revenue of USD 13.0 million in 2023 and is expected to reach USD 25.9 million by 2030.
- The India market is expected to grow at a CAGR of 10.3% from 2024 to 2030.
- In terms of segment, ck was the largest revenue generating type in 2023.
- CRP is the most lucrative type segment registering the fastest growth during the forecast period.
Blood-based biomaker for sports medicine market data book summary
| Market revenue in 2023 | USD 13.0 million |
| Market revenue in 2030 | USD 25.9 million |
| Growth rate | 10.3% (CAGR from 2023 to 2030) |
| Largest segment | Ck |
| Fastest growing segment | CRP |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CK, Myoglobin, Lactate, WBC, Urea, CRP, Lipid and Protein Hydroperoxides, IL-6 |
Other key industry trends
- In terms of revenue, India accounted for 2.0% of the global blood-based biomaker for sports medicine market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China blood-based biomaker for sports medicine market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 25.9 million by 2030.
Ck was the largest segment with a revenue share of 18.46% in 2023. Horizon Databook has segmented the India blood-based biomaker for sports medicine market based on ck, myoglobin, lactate, wbc, urea, crp, lipid and protein hydroperoxides, il-6 covering the revenue growth of each sub-segment from 2018 to 2030.
In India, the rate of sports injuries, particularly among young athletes, has seen a sharp rise over the past 10 to 15 years. Football and cricket players are experiencing a 500% increase in knee & ankle injuries, while Anterior Cruciate Ligament (ACL) injuries have surged by 400%. This alarming trend highlights the growing need for advanced injury prevention and management strategies.
In addition, according to a September 2020 report in the Journal of Clinical and Diagnostic Research, it was found that 42.5% of the 80 players studied were injured, and 62.5% had sustained injuries in the past 2 years. Among upper limb injuries, the shoulder was the most frequently affected area (21.25%), followed by the arm (5%).
As a result, the demand for blood-based biomarkers in sports medicine is gaining momentum in India. These biomarkers offer critical insights into injury risk, recovery, and overall athlete health, enabling more personalized and effective treatment plans.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Blood-based Biomaker for Sports Medicine Market Scope
Blood-based Biomaker for Sports Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
India blood-based biomaker for sports medicine market size, by type, 2018-2030 (US$M)
India Blood-based Biomaker for Sports Medicine Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
